AU2002358914A1 - Cancer prognosis using thymosin beta10 (tbeta10) - Google Patents

Cancer prognosis using thymosin beta10 (tbeta10)

Info

Publication number
AU2002358914A1
AU2002358914A1 AU2002358914A AU2002358914A AU2002358914A1 AU 2002358914 A1 AU2002358914 A1 AU 2002358914A1 AU 2002358914 A AU2002358914 A AU 2002358914A AU 2002358914 A AU2002358914 A AU 2002358914A AU 2002358914 A1 AU2002358914 A1 AU 2002358914A1
Authority
AU
Australia
Prior art keywords
tbeta10
beta10
thymosin
cancer prognosis
prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002358914A
Other versions
AU2002358914A8 (en
Inventor
Nikiforos Apostolikas
Grigorios Evangelatos
Dionysios ITHAKISSIOS
Leondios Leondiadis
Evangelia Livaniou
Susana Verghese-Nikolakaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FARAN LABORATORIES SA
National Center for Scientific Research Demokritos
Original Assignee
Faran Lab S A
National Center for Scientific Research Demokritos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faran Lab S A, National Center for Scientific Research Demokritos filed Critical Faran Lab S A
Publication of AU2002358914A1 publication Critical patent/AU2002358914A1/en
Publication of AU2002358914A8 publication Critical patent/AU2002358914A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5759—Thymosin or related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2002358914A 2001-11-28 2002-11-28 Cancer prognosis using thymosin beta10 (tbeta10) Abandoned AU2002358914A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR20010100543 2001-11-28
GR20010100543A GR1004636B (en) 2001-11-28 2001-11-28 CANCER PROGNOSIS USING THYMOSIN b10 (Tb10)
PCT/GR2002/000060 WO2003046582A2 (en) 2001-11-28 2002-11-28 CANCER PROGNOSIS USING THYMOSIN β10 (Tβ10)

Publications (2)

Publication Number Publication Date
AU2002358914A1 true AU2002358914A1 (en) 2003-06-10
AU2002358914A8 AU2002358914A8 (en) 2003-06-10

Family

ID=10944841

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002358914A Abandoned AU2002358914A1 (en) 2001-11-28 2002-11-28 Cancer prognosis using thymosin beta10 (tbeta10)

Country Status (3)

Country Link
AU (1) AU2002358914A1 (en)
GR (1) GR1004636B (en)
WO (1) WO2003046582A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103940658A (en) * 2014-04-10 2014-07-23 青岛大学医学院附属医院 Method for manufacturing paraffin-embedded tissue cell specimen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248591A (en) * 1991-05-02 1993-09-28 Puente Fernando D Diagnosis of cancer and other proliferative disorders by analysis of prothymosin alpha expression
US5858681A (en) * 1996-06-17 1999-01-12 Children's Medical Center Method for prognosis of prostate cancer

Also Published As

Publication number Publication date
GR1004636B (en) 2004-07-14
AU2002358914A8 (en) 2003-06-10
WO2003046582A2 (en) 2003-06-05
WO2003046582A3 (en) 2004-02-05
GR20010100543A (en) 2003-07-16
WO2003046582A8 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AU2002360766A1 (en) Methods for cancer imaging
AU2002251205A1 (en) Multi-modal interface
AUPR395801A0 (en) Antibodies against cancer
AU2001210409A1 (en) Touchpad
AUPR969501A0 (en) Forfaiting transactions
AU2002338574A1 (en) Compensation-data processing
AU2001290860A1 (en) Spas-1 cancer antigen
AU7135500A (en) Slide latch
AU2002359464A1 (en) Angiopioetin related factors
AU2002232034A1 (en) Substrate linked directed evolution (slide)
AU2003272964A1 (en) Remedy for hormone-dependent cancer
AU2002354567A1 (en) Not given
AU2002358914A1 (en) Cancer prognosis using thymosin beta10 (tbeta10)
AUPR811501A0 (en) Voucher processing
AU2002309668A1 (en) Methods for determining the prognosis for cancer patients using tucan
AU2002233399A1 (en) Loader
AU2002229798A1 (en) Loader
AU2002240511A1 (en) Quantitative immunohistochemistry (qihc)
AU2002302838A1 (en) Cancer associated protein
AU2002351789A1 (en) $g(d)1-pyrrolines
AUPR726301A0 (en) Payment
AU2002223959A1 (en) Buoyant divisor
AU2002312397A1 (en) Haplotype determination
AU2002332585A1 (en) Penlatch notebook

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase